Wellorithm Review 2026: Cost, Legitimacy, and GLP-1 Options

Quick answer: Is Wellorithm legitimate?

Wellorithm appears to be an active telehealth weight-management program rather than an anonymous lead-generation page. It maintains a current public homepage, GLP-1 campaign, Terms, privacy/contact pages, and patient login. Its Terms say Wellorithm acts as a facilitator connecting users with licensed healthcare professionals rather than practicing medicine itself.

The current campaign also names three physicians it says Wellorithm has partnered with: Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD, and Dr. David Mansour DO. That is a useful transparency improvement, but Care Path Compare has not independently verified their current licenses, state coverage, contractual roles, or whether any of them would treat a particular user.

Important questions remain. Current public pages do not clearly identify the formal operating legal entity, dispensing pharmacy, laboratory requirements, or a reconciled product-by-state availability list. The homepage and campaign say 49 states and exclude Louisiana, while the Terms say all 50 states plus Washington, D.C. Marketing also says no membership or hidden fees and free shipping, while the Terms describe a cash-pay membership and say prices exclude shipping and taxes.

The campaign also uses much broader social-proof and warranty language than the formal Terms. One current campaign presentation advertises more than 10,000 reviews and a 365-day money-back guarantee, while the public Trustpilot profile for wellorithm.com showed only two reviews and a 3.3 TrustScore when checked September 16, 2026. The formal Terms separately describe a conditional 16-week guarantee. Those sources measure different things, so the small Trustpilot sample does not disprove Wellorithm’s broader review-count claim; it does mean consumers should ask where the larger review total comes from and which written guarantee governs their purchase.

Our assessment: Wellorithm is an active program worth comparing, but important provider and commercial disclosures remain internally inconsistent. Confirm the exact charge, renewal terms, treating clinician and medical entity, pharmacy, formulation, state availability, shipping, and refund terms in the checkout and governing agreement before enrolling.

Affiliate disclosure: Care Path Compare may receive compensation if you use a Wellorithm link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Wellorithm at a glance

Information was checked September 16, 2026 and can change.

How Wellorithm says the program works

Wellorithm’s public pages describe a familiar telehealth sequence:

1. Complete an online assessment.
2. Continue to a virtual consultation or clinician review.
3. Receive a treatment recommendation only if a clinician considers it appropriate.
4. Have prescribed medication processed and shipped.
5. Use the patient portal for ongoing support, messaging, visits, and account management.

The current campaign names Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD, and Dr. David Mansour DO as physician partners. A public patient-login page also remains online. Neither point establishes which professional entity or clinician would be responsible for an individual patient’s care, and the dispensing pharmacy is still not named in the public sources reviewed.

An initial quiz result is not medical approval. Eligibility, prescribing, medication selection, dosage, monitoring, and state availability depend on clinician review and the organizations involved in the individual case.

What medications does Wellorithm advertise?

Compounded semaglutide

Wellorithm advertises compounded semaglutide as an injection and as an oral-dissolving tablet. These are compounded products, not FDA-approved versions of Wegovy or Ozempic and not FDA-approved generics.

FDA says compounded drugs do not undergo its premarket review for safety, effectiveness, or quality. FDA also advises consumers to obtain a prescription from a licensed clinician and use a state-licensed pharmacy. For a compounded semaglutide order, ask for the exact active ingredient, dosage form, concentration, pharmacy, storage instructions, and directions for measuring the dose.

The oral-dissolving presentation deserves additional caution. Evidence from FDA-approved injectable semaglutide should not automatically be applied to a compounded oral-dissolving formulation.

Compounded tirzepatide

Wellorithm also advertises compounded tirzepatide injections and oral-dissolving tablets. These compounded products are not FDA-approved Zepbound or Mounjaro and should not be described as generic or equivalent versions of those brands.

Ask the clinician why a compounded product is being considered, which pharmacy would prepare it, how the formulation differs from an approved product, and what monitoring or follow-up applies.

Wegovy and Zepbound

Wegovy and Zepbound are FDA-approved branded medications with weight-management indications for defined patient populations. Wellorithm’s current campaign advertises starting prices of $899 for Wegovy and $1,199 for Zepbound. Those figures do not guarantee eligibility, prescribing, insurance coverage, inventory, included services, or the final checkout total.

FDA approved Zepbound for chronic weight management and later for certain adults with obesity and moderate-to-severe obstructive sleep apnea. A provider’s marketing page does not change an FDA-approved indication or establish that a medication is appropriate for an individual user.

Ozempic and Mounjaro

Wellorithm’s current campaign advertises starting prices of $1,199 for Ozempic and $1,399 for Mounjaro. Ozempic and Mounjaro are branded diabetes medications. A licensed clinician may discuss an off-label use when medically appropriate, but consumers should not assume that a provider’s weight-loss landing page changes the FDA-approved indication or guarantees that the medication will be prescribed.

Ask which branded product is actually being considered, for what indication, whether the clinician is discussing an off-label use, and what alternatives may apply.

How much does Wellorithm cost?

The current default campaign advertises compounded semaglutide starting at $147 and compounded tirzepatide starting at $249, with $100 off the first month. Those are promotional entry prices, not verified standard renewal prices.

The same campaign currently lists branded starting prices of $899 for Wegovy, $1,199 for Ozempic, $1,399 for Mounjaro, and $1,199 for Zepbound.

Affiliate disclosure: Care Path Compare may receive compensation if you use a Wellorithm link and make a purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Treat each branded figure as an advertised starting price rather than a guaranteed recurring or checkout total.

Before paying, confirm:

• the exact product and formulation;
• today’s charge;
• whether a promotion is included;
• the standard recurring charge;
• whether billing is monthly or every 28 days;
• whether a multi-month commitment applies;
• whether price changes with dose;
• whether clinician visits, medication, supplies, shipping, and taxes are included; and
• the date of the next automatic charge.

Our online GLP-1 program cost guide explains how to compare promotional pricing with the likely recurring total.

What does the program include?

Wellorithm’s marketing pages describe clinician review, virtual appointments, ongoing messaging, coaching, medication shipment, and support. The default campaign says there are no membership or hidden fees and that everything needed is included.

The formal terms are less expansive. They describe a cash-pay membership, recurring fees, and prices that exclude shipping and taxes. Because those statements do not fully align, consumers should rely on the final checkout agreement rather than the broad marketing summary.

The public materials did not clearly establish:

• how many clinician visits are included;
• whether response times are guaranteed;
• whether laboratory testing is required;
• whether laboratory costs are included;
• whether supplies differ by formulation;
• whether taxes or shipping can be added; or
• whether a separate pharmacy charge can appear.

Clinician and company transparency

Physicians named on the current campaign

Wellorithm’s current GLP-1 campaign names Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD, and Dr. David Mansour DO as physicians it has partnered with. Naming clinicians is more transparent than referring only to a generic medical team, but it does not establish who would evaluate or treat a particular patient.

Care Path Compare has not independently verified those physicians’ current licenses, state coverage, contractual roles with Wellorithm, or participation in every Wellorithm pathway. Before treatment, ask which clinician and professional entity would be responsible for your care and verify the clinician’s license in your state.

Patel Group PC

The public patient-portal code says medical services are facilitated by independent providers and Patel Group PC. We did not independently confirm Patel Group PC’s registrations, clinician roster, license coverage, or role in every Wellorithm pathway.

The current campaign’s physician names and the portal’s Patel Group PC reference should therefore be treated as separate transparency clues, not proof that the named physicians work through Patel Group PC or that Patel Group PC is responsible for every user.

CareValidate and Care360

CareValidate Inc. supplies the Care360 case-management platform used by the Wellorithm portal. That is a technology relationship. It does not make CareValidate the prescribing clinician, medical group, dispensing pharmacy, or operator of the Wellorithm brand.

Operating legal entity

The formal operating legal entity behind Wellorithm was not clearly identified on the public pages reviewed. Structured data identifies the brand as “wellorithm” and lists a Miami address, but it does not provide a corporate legal name.

A similarly named Florida business record is not enough to establish who operates the telehealth program. Consumers should request the legal contracting entity shown on the receipt, consent forms, privacy documents, and recurring-billing authorization.

Pharmacy transparency and medication delivery

Wellorithm’s pages describe medication shipment, and its privacy policy refers generally to pharmacies. The reviewed pages and public portal did not name the pharmacy that would dispense compounded or branded medication.

That is a meaningful gap for a program advertising compounded products. Before an order is processed, request:

• the pharmacy’s full legal name and location;
• the pharmacy license and the states it serves;
• the exact formulation and concentration;
• the active ingredient and any added ingredients;
• storage and refrigeration requirements;
• the beyond-use date;
• the delivery-temperature policy;
• the process for a warm, delayed, damaged, or missing shipment; and
• the contact for medication questions.

FDA recommends verifying that compounded medication is prescribed by a licensed clinician and filled by a state-licensed pharmacy. FDA has also warned about fraudulent labels, improper shipping temperatures, and dosing errors involving compounded GLP-1 products.

Are laboratory tests required?

Wellorithm’s public pages did not clearly explain whether laboratory testing is always required, sometimes required based on medical history, or not required. We also did not find a named laboratory provider, testing schedule, or public laboratory price.

Ask before enrollment whether labs may be ordered, what tests could be required, where they can be completed, who reviews the results, and whether the cost is included.

State availability

Wellorithm’s public pages do not provide one consistent answer:

• the default campaign and homepage say the program serves 49 states and excludes Louisiana; and
• the Terms say services are available in all 50 states plus Washington, D.C.

Those statements cannot both describe the same current rule. Confirm availability for the exact medication, formulation, clinician, and pharmacy in your state before relying on a general nationwide claim.

Cancellation, renewal, and refunds

Wellorithm’s terms describe membership fees billed every 28 days. They say users can cancel by email, but a payment is nonrefundable after it has been processed for the current cycle.

“Cancel anytime” therefore appears to mean cancel future cycles, not reverse a completed charge. Before paying, confirm:

1. the cancellation email address or portal method;
2. how many days before the next billing date a request must arrive;
3. when a payment is considered processed;
4. whether clinician review or pharmacy processing changes refund eligibility;
5. whether a prepaid or financed plan has different rules; and
6. how a refund affects any buy-now-pay-later obligation.

See our telehealth cancellation and refund guide for a checklist to save before enrollment.

How do Wellorithm’s guarantee claims compare?

Wellorithm’s formal Terms describe a conditional policy under which some new users who do not lose at least 10% of baseline weight after 16 weeks may qualify for a refund of up to four months of fees.

This is not an unconditional outcome or money-back promise. The written conditions include:

• new-user eligibility;
• completion of required intake reporting;
• adherence to the prescribed dosing plan for 16 weeks;
• restrictions related to prior weight-loss medication use;
• formal weight verification;
• review and approval of the claim; and
• a refund limited to fees actually paid.

A current Wellorithm campaign presentation uses broader language, including a 365-day money-back guarantee and a statement that users who follow the plan but do not reach their Wellorithm goal can receive a refund. The campaign and Terms therefore do not present the warranty in the same way.

Care Path Compare does not treat either marketing statement as an assured weight-loss outcome. Before relying on the warranty, ask Wellorithm which written policy applies to the exact plan being purchased, whether the 16-week Terms still control, what documentation is required, what fees are refundable, and whether any exclusions apply. Save the checkout terms and warranty language in effect on the purchase date.

What do Wellorithm reviews establish?

Wellorithm’s campaign uses large social-proof claims, including more than 10,000 reviews in one current presentation. Care Path Compare could not independently reproduce that review total from the public Trustpilot profile for wellorithm.com.

When checked September 16, 2026, Trustpilot showed a claimed Wellorithm profile with 2 reviews and a 3.3 TrustScore. Trustpilot itself noted that the company had no recent history of asking for reviews and that the small sample may not be representative. One review was positive and one was negative. A two-review sample is far too small to estimate typical customer experience.

This does not establish that Wellorithm’s broader review-count claim is false. The company may be counting feedback collected on another platform, through surveys, or through a different review process. The useful consumer question is therefore: what source, time period, and methodology produce the larger review number?

We do not use either Wellorithm’s promotional testimonials or the tiny Trustpilot sample to infer medication quality, clinician competence, pharmacy quality, or expected health outcomes. Reviews are best used here to identify questions about service, billing, delivery, support, and refund handling that should be verified against written terms.

Main strengths

• Current public pages display starting prices for compounded and branded pathways.
• Five supplied GLP-1 affiliate destinations resolved to matching product or program pages.
• The current campaign names three physicians it says are partnered with Wellorithm.
• The terms explain recurring billing, cancellation, nonrefundability, and the conditional guarantee in more detail than the main campaign.
• The public portal identifies a technology platform and a professional medical entity.
• Current pages state that compounded products are not FDA-approved.
• The program advertises both compounded and branded pathways, allowing consumers to ask about different models in one intake.

Main limitations and unresolved questions

• The operating legal entity is not clearly identified.
• The campaign names three physicians, but their current licenses, state coverage, contractual roles, and participation in individual care have not been independently verified by Care Path Compare.
• Patel Group PC’s role, registrations, clinicians, and state coverage remain unverified.
• No dispensing pharmacy is named publicly.
• Laboratory requirements and costs are unclear.
• Compounded starting prices do not reveal standard renewal or formulation-specific costs.
• Branded prices are starting figures and do not establish the final checkout total, included services, prescribing eligibility, or inventory.
• Shipping, tax, insurance, and hidden-fee language is inconsistent.
• State-availability statements conflict.
• Contact-address and some template elements raise additional transparency questions.
• Campaign warranty language and the formal Terms describe materially different guarantee structures.
• Campaign review-count claims are not reproduced by the small public Trustpilot sample; the source and methodology for the larger number are not clearly disclosed.
• Broad campaign guarantee, testimonial, and outcome language should not be interpreted as an assured or typical result.

Who may find Wellorithm worth comparing?

Wellorithm may be worth comparing for adults who want to research both compounded and branded GLP-1 pathways through one telehealth intake and who are comfortable confirming commercial details directly before paying.

It may be less suitable for someone who wants the operating company, medical group, dispensing pharmacy, laboratory policy, state coverage, and exact renewal total clearly disclosed before beginning an intake.

Questions to ask before paying

1. What legal entity will charge my card and appear on my receipt?
2. Which professional medical entity and clinician would be responsible for my care?
3. Is the clinician licensed in my state?
4. What exact medication, formulation, route, and concentration would be prescribed if I qualify?
5. Which pharmacy would dispense it, and how can I verify that pharmacy’s license?
6. What amount will be charged today?
7. What is the standard recurring charge after the promotion?
8. Is billing monthly, every 28 days, prepaid, financed, or subject to a commitment?
9. Are shipping, taxes, supplies, clinician visits, and laboratory tests included?
10. What is the cancellation deadline before the next charge?
11. When does the current order become nonrefundable?
12. For a branded pathway, what exactly is included in the advertised starting price and what is the final checkout total?
13. Is the exact pathway available in my state, including clinician and pharmacy coverage?
14. Are labs required, and who pays for them?
15. Which written guarantee controls my purchase: the campaign warranty language, the 16-week Terms policy, or another checkout-specific document?
16. What source and methodology support the campaign’s larger review-count claim?

Bottom line

Wellorithm has enough public infrastructure and commercial detail to be researched as an active telehealth option. Its strongest consumer-facing transparency improvements are the current compounded and branded starting prices, the campaign’s physician names, recurring-service terms, and a portal disclosure naming the technology platform and a professional entity.

The remaining transparency gaps are substantial. The operating legal entity, exact treating medical entity, pharmacy, labs, compounded renewal pricing, final checkout total, and product-by-state availability remain unresolved or conflicting. The campaign’s broad warranty, review-count, testimonial, and outcome language also does not line up cleanly with the formal Terms or the small independent Trustpilot sample. Consumers should verify the source of social-proof claims and save the exact warranty and checkout terms that apply to their purchase.

Compare the final written terms—not just the headline price—and talk with a licensed clinician about whether any treatment is appropriate for your individual circumstances.

Affiliate disclosure: Care Path Compare may receive compensation if you use a Wellorithm link and make a purchase, at no extra cost to you. Our research standards and editorial conclusions are independent of compensation.

How we reviewed Wellorithm

We reviewed Wellorithm’s official homepage, default affiliate campaign, dedicated branded-medication pages, terms, privacy policy, contact page, quiz entry page, public patient-portal login, and the public Trustpilot profile for wellorithm.com. We followed the approved affiliate destinations through their redirects, captured public commercial terms, inspected public structured data and portal disclosures, and compared medication-status statements with FDA sources.

We did not submit intake answers, personal information, health information, account registration, payment details, or a purchase. We did not receive care, medication, or a pharmacy assignment. This is a source-based editorial review, not a personal-treatment review.

Medical disclaimer: This page is for general educational and comparison purposes and is not medical advice. Prescription treatment requires evaluation by a licensed healthcare professional. Eligibility, medication choice, dosage, monitoring, and outcomes vary. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.